ACT on Vaping: Pilot Randomized Controlled Trial of a Novel Digital Health App With Text Messaging for Young Adult Vaping Cessation
Open Access
- 24 May 2025
- journal article
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (5) , 720-730
Abstract
Background: There is no published evidence to support the efficacy of any digital vaping cessation program for young adults (YAs) at differing levels of readiness to quit. In this pilot randomized controlled trial, we evaluated the preliminary acceptability and efficacy of a program for vaping cessation based on acceptance and commitment therapy (ACT on Vaping), delivered via a smartphone app and text messaging. Methods: YAs aged 18–30 (n = 61) were randomized 1:1 to ACT on Vaping (n = 31) or incentivized text message control (n = 30). Outcome data were collected at 3 months post-randomization. Results were compared against a priori benchmarks for acceptability (satisfaction of ≥3.5 on 5-point scale) and efficacy relative to control (meeting at least one of three): ≥1-point difference in Contemplation Ladder change scores; ≥5 percentage difference in 24-hour quit attempts, ≥5 percentage difference in cotinine-confirmed 30-day point prevalence abstinence (PPA) from all non-therapeutic nicotine/tobacco. Results: Satisfaction with ACT on Vaping averaged 3.8, exceeding the acceptability benchmark. A higher proportion of participants in the ACT on Vaping arm reported a 24-hour quit attempt (87.5% vs. 75.9%), exceeding the efficacy benchmark. Both changes in quit readiness (+0.96 in ACT on Vaping vs. +0.72 in control) and cotinine-confirmed 30-day PPA (4.2% in ACT on Vaping vs. 0% in control) were descriptively higher for ACT on Vaping but did not reach the benchmark level for efficacy. Conclusions: ACT on Vaping had promising acceptability and preliminary efficacy. A fully powered trial of ACT on Vaping is warranted to evaluate its efficacy. Implications: Digital interventions are a promising yet under-researched approach for reaching and supporting YAs to quit vaping. This proof-of-concept pilot randomized controlled trial evaluated a novel mobile health application and associated text messaging program (ACT on Vaping) for young adult vaping cessation and found preliminary evidence for acceptability and efficacy relative to an incentivized text message control arm, warranting evaluation in a fully powered trial as a next step. Trial registration: NCT05897242Keywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse (UGDA3057032)
This publication has 38 references indexed in Scilit:
- Interventions for quitting vapingCochrane Database of Systematic Reviews, 2025
- A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealthDrug and Alcohol Dependence, 2022
- A synthesis of the literature to inform vaping cessation interventions for young adultsAddictive Behaviors, 2021
- Effectiveness of a Vaping Cessation Text Message Program Among Young Adult e-Cigarette UsersJAMA Internal Medicine, 2021
- Using Digital Technologies to Reach Tobacco Users Who Want to Quit: Evidence From the National Cancer Institute's Smokefree.gov InitiativeAmerican Journal of Preventive Medicine, 2021
- Efficacy of Smartphone Applications for Smoking CessationJAMA Internal Medicine, 2020
- Smoking-Cessation Interventions for U.S. Young Adults: Updated Systematic ReviewAmerican Journal of Preventive Medicine, 2020
- Mobile phone text messaging and app-based interventions for smoking cessationCochrane Database of Systematic Reviews, 2019
- Acceptance and Commitment Therapy, Relational Frame Theory, and the Third Wave of Behavioral and Cognitive Therapies – Republished ArticleBehavior Therapy, 2016
- Acceptance and Commitment Therapy: Model, processes and outcomesBehaviour Research and Therapy, 2006